Article
Could Chinese cardiovascular chronic conditions patients gain benefits from pharmaceutical services? A multilevel meta-analysis
2024-07-25
Abstract excerpt
<h4>Background</h4> The value of pharmaceutical services for Chinese patients with cardiovascular chronic conditions was not recognized. <h4>Aim</h4> To investigate the comprehensive value of pharmaceutical services in China and find factors influencing patient benefits. <h4>Design and setting</h4> This was a systematic review with multilevel meta-analysis of 183 randomized control trials focusing on the benefits...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 47553481-2e80-5de7-953a-da556f43c6de
- DOI
- 10.1101/2024.07.25.24310734
